Acute Kawasaki Disease: Not Just for Kids
Case Reports/Case Vignettes
First Online: 18 January 2007 DOI:
Cite this article as: Wolff, A.E., Hansen, K.E. & Zakowski, L. J GEN INTERN MED (2007) 22: 681. doi:10.1007/s11606-006-0100-5
Kawasaki Disease is a small-to-medium-vessel vasculitis that preferentially affects children. Kawasaki Disease can occur in adults, but the presentation may differ from that observed in children. Typical findings in both adults and children include fever, conjunctivitis, pharyngitis, and skin erythema progressing to a desquamating rash on the palms and soles. Adults more frequently present with cervical adenopathy (93% of adults vs. 15% of children), hepatitis (65% vs. 10%), and arthralgia (61% vs. 24–38%). In contrast, adults are less frequently affected by meningitis (10% vs. 34%), thrombocytosis (55% vs. 100%), and coronary artery aneurysms (5% vs. 18–25%). We report a case of acute Kawasaki Disease in a 24-year-old man who presented with rash, fever, and arthritis. He was successfully treated with high-dose aspirin and intravenous immunoglobulin (IVIG). Our case highlights the importance of considering Kawasaki Disease in adults presenting with symptoms commonly encountered in a general medical practice.
Key words Kawasaki Disease adult coronary artery aneurysms vasculitis adenopathy arthritis mucocutaneous lymph node syndrome References
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease. Circulation. 2004;2747–71.
Sève P, Stankovic K, Smail A, Durand DV, Marchand G, Broussolle C.
Adult Kawasaki Disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785–92.
Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki Disease in 1997 and 1998 in Japan. Pediatrics. 2005;107:1–4.
Childhood vasculitis. Lupus. 1998;7:259–65.
Burns JC, Cayan DR, Tong G, et al.
Seasonality and temporal clustering of Kawasaki Syndrome. Epidemiology. 2005;16:220–5.
Leung DY, Schlievert PM, Meissner HC.
The immunopathogenesis and management of Kawasaki Syndrome. Arthritis Rheum. 1998;41:1538–47.
Long S. Principles and Practice of Pediatric Infectious Diseases 2nd edition: Chapter 14-Mucocutaneous Symptom Complexes. New York: Churchill Livingstone; 2003:103–8.
Falcini F, Trapani S, Turchini S, et al.
Immunological findings in Kawasaki Disease: an evaluation in a cohort of Italian children. Clin Exp Rheumatol. 1997;15:685–9.
Rider LG, Wener MH, French J, Sherry DD, Mendelman PM.
Autoantibody production in Kawasaki syndrome. Clin Exp Rheumatol. 1993;11:445–9.
Tomiyama J, Hasegawa Y, Kumagai Y, Adachi Y, Karasawa K.
Acute febrile mucocutaneous lynph node syndrome (Kawasaki disease) in adults: case report and review of the literature. Jpn J Med. 1991;30:285–9.
Hansen KE, Arnason J, Bridges A.
Autoantibodies and common viral illnesses. Semin Arthritis Rheum. 1998;27:263–71.
Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB.
Evidence for superantigen involvement in cardiovascular injury due to Kawasaki Syndrome. J Immunol. 1995;155:5018-21.
Rauch AM, Glode MP, Wiggins JW, et al.
Outbreak of Kawasaki Syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics. 1991;87:663–9.
Jackson JL, Kunkel MR, Libow L, Gates RH.
Adult Kawasaki Disease: report of two cases treated with intravenous gamma globulin. Arch Intern Med. 1994;154:1398–405.
Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki Disease in the adult: a case report and review of the literature. Texas Heart Inst J. 2004;31:160–4.
Newburger JW, Takahashi M, Burns JC, et al.
The treatment of Kawasaki Syndrome with intravenous gamma globulin. New Engl J Med. 1986;315:341–7.
Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki Disease. 1985;254:767–9.
Furusho K, Nakano H, Shinomiya K, et al.
High dose intravenous gamma globulin for Kawasaki Disease. Lancet. 1984;2:1055–8.
Newburger JW, Takahasi M, Beiser AS, et al.
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki Syndrome. New Engl J Med. 1991;324:1633–9.
Oates-Whitehead RM, Baumer JH, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003;(4):CD004000.
Bayrou O, Phlippoteau C, Artigou C, Haddad T, Leynadier F.
Adult Kawasaki syndrome associated with HIV infection and anti-cardiolipin antibodies. J Am Acad Dermatol. 1993;29:663–4.
Fason JT, Fry YW, Smith D.
Kawasaki Disease in a postpartum patient. J Natl Med Assoc. 2004;96:1499–1502.
Kato H, Koike S, Yokoyama T.
Kawasaki Disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175–9.
Sundel RP, Baker AL, Fulton DR, Newburger JW.
Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003;142:611–6.
Wooditch AC, Aronoff SC.
Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics. 2005;116:989.
PubMed CrossRef Copyright information
© Society of General Internal Medicine 2007